(Press-News.org) The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets for drug discovery that could be exploited to combat the disease. The study gives the most detailed understanding yet of the complex processes leading to Alzheimer's.
Alzheimer's disease is associated with plaques made up of deposits of a molecule called amyloid between brain cells, which leads to the formation of tangles of twisted fibres made from a molecule called tau, found inside the brain cells. This causes the death of brain cells which is thought to bring about the symptoms of memory loss and dementia. Although it has been accepted for over twenty years that the progression of disease is driven by amyloid and results in abnormal changes in tau, the exact mechanisms of disease remain somewhat of a mystery.
Recent genome wide association studies have identified the gene for a molecule called clusterin as a susceptibility factor for late-onset Alzheimer's disease. Levels of clusterin are also known to be elevated in blood in patients with Alzheimer's from an early stage in the disease so the researchers wanted to find out what role it might play in the progression of disease.
The team, led by researchers at King's College London's Institute of Psychiatry, looked first in mouse brain cells grown in the laboratory and found that the presence of amyloid alters the amount of clusterin in these cells. Clusterin then acts to switch on a signalling pathway that drives the changes in tau that are associated with the formation of tangles inside the cells, another hallmark of the disease. When this signalling pathway was chronically switched on in a mouse model of the disease, the researchers observed an increase in tangle formation and evidence of cognitive defects.
The study, published today in the journal Molecular Psychiatry, also looked in humans and detected the signature of clusterin activation in the brains of Alzheimer's patients but not in the brains of patients with other forms of dementia.
Dr Richard Killick from King's College London's Institute of Psychiatry said: "This is the first time we've been able to connect the molecular mechanisms behind the formation of amyloid plaques in the brain with the formation of tangles inside the brain cells, two of the defining features of Alzheimer's disease. Our research has given the most detailed picture yet of how the disease progresses and we hope it will offer leads for the development of new treatments."
The signalling pathway that is turned on by clusterin is called DKK1-WNT. It involves interactions between a number of different molecules that could prove to be useful targets for the development of new drugs.
Current treatments for Alzheimer's are focused on alleviating the symptoms and there is no therapy that can prevent the progression of disease.
Professor Simon Lovestone, also from King's College London's Institute of Psychiatry, who led the study, said: "We have shown that we can block the toxic effects of amyloid when we stop this signalling pathway in brain cells grown in the lab. We believe that if we could block its activity in the brains of Alzheimer's patients too, we may have an opportunity to halt the disease in man. Indeed, we have already begun our own drug development programme to do just that and are at the stage where potential compounds are coming back to us for further testing."
The DKK1-WNT pathways has also been implicated in some human cancers and although there is no evidence for a direct link, the findings from this study mean that there could be an opportunity to make advances in Alzheimer's research by capitalising on knowledge that is being gained from cancer research, the authors suggest.
Dr John Williams, Head of Neuroscience and Mental Health at the Wellcome Trust, which helped fund this study, said: "We will see more and more people affected by Alzheimer's disease as our population ages. This study gives us a much-needed additional insight to the complex biology that contributes to the development of Alzheimer's, which is vital if we are to develop new treatments that are so urgently needed."
###The study was largely funded by the Wellcome Trust, the Alzheimer's Society, BUPA foundation and Alzheimer's Research UK.
Discovery of molecular pathway of Alzheimer's disease reveals new drug targets
2012-11-20
ELSE PRESS RELEASES FROM THIS DATE:
Frequency of alcohol consumption and cardiovascular risk factors
2012-11-20
Critique 096: Frequency of alcohol consumption and cardiovascular risk factors: implications for drinking guidelines 20 November 2012
Read the full critique here: http://www.bu.edu/alcohol-forum/critique-096-frequency-of-alcohol-consumption-and-cardiovascular-risk-factors-implications-for-drinking-guidelines-20-november-2012/
The purpose of this paper was to examine whether drinkers who consume lower-risk amounts on more frequent occasions have favourable risk factor profiles compared with those who drink more per occasion but less frequently. The authors also discuss ...
Dance boosts young girls' mental health
2012-11-20
Young girls can dance their way to better mental health. Symptoms like depression, stress, fatigue, and headaches are alleviated with regular dancing. This is shown in a study run by Anna Duberg, a physical therapist at Örebro University Hospital and a doctoral candidate at Örebro University in Sweden. Regular dance training can thereby be regarded as a strategy for preventing and treating low spirits and depression. Dance also brings enhanced self-esteem and a greater capacity to deal with everyday problems.
The dance study included 112 Swedish girls 13 to 19 years ...
Scientists at Mainz University identify inhibitor of myelin formation in the central nervous system
2012-11-20
Scientists at the Mainz University Medical Center have discovered another molecule that plays an important role in regulating myelin formation in the central nervous system. Myelin promotes the conduction of nerve cell impulses by forming a sheath around their projections, the so-called axons, at specific locations – acting like the plastic insulation around a power cord. The research team, led by Dr. Robin White of the Institute of Physiology and Pathophysiology at the University Medical Center of Johannes Gutenberg University Mainz, recently published their findings in ...
Researchers build synthetic membrane channels out of DNA
2012-11-20
As reported in the journal Science, physicists at the Technische Universitaet Muenchen (TUM) and the University of Michigan have shown that synthetic membrane channels can be constructed through "DNA nanotechnology." This technique employs DNA molecules as programmable building materials for custom-designed, self-assembling, nanometer-scale structures. The researchers present evidence that their nature-inspired nanostructures may also behave like biological ion channels. Their results could mark a step toward applications of synthetic membrane channels as molecular sensors, ...
Is Facebook a factor in psychotic symptoms?
2012-11-20
As Internet access becomes increasingly widespread, so do related psychopathologies such as Internet addiction and delusions related to the technology and to virtual relationships. Computer communications such as Facebook and chat groups are an important part of this story, says Dr. Uri Nitzan of Tel Aviv University's Sackler Faculty of Medicine and the Shalvata Mental Health Care Center in a new paper published in the Israel Journal of Psychiatry and Related Sciences.
In his study, the researcher presented three in-depth case studies linking psychotic episodes to Internet ...
How healthy are young people's lifestyles?
2012-11-20
This is the question asked by two of the articles in this week's issue of Deutsches Ärzteblatt International. Dieter Leyk from German Sport University Cologne (Deutsche Sporthochschule Köln) and coauthors investigated the effects of unhealthy lifestyles on young people's fitness, Sabine Stamm-Balderjahn from Berlin's Charité, and her coauthors report a study investigating the effects of a hospital-based intervention program to prevent smoking in school students (Dtsch Arztebl Int 2012; 109(44): 737-45 und Dtsch Arztebl Int 2012; 109(44): 746-52).
Leyk et al. collected ...
Researchers implicate well-known protein in fibrosis
2012-11-20
Chicago --- An international multi-disciplinary research team led by Northwestern Medicine scientists has uncovered a new role for the protein toll-like receptor 4 (TLR4) in the development of tissue fibrosis, or scarring.
This finding, recently reported in the American Journal of Pathology, has implications for the treatment of scleroderma, a condition for which there currently is no effective treatment.
TLR4 was previously implicated in inflammation, but its role in tissue fibrosis was unknown. Fibrosis is a hallmark of scleroderma and contributes to a range of common ...
Teens in arts report depressive symptoms, study says
2012-11-20
WASHINGTON – Teens who participate in after-school arts activities such as music, drama and painting are more likely to report feeling depressed or sad than students who are not involved in these programs, according to new research published by the American Psychological Association.
This is the first study to find that young people's casual involvement in the arts could be linked to depressive symptoms, according to the researchers. The article was published online in APA's journal Psychology of Aesthetics, Creativity, and the Arts.
"This is not to say that depression ...
Planck spots hot gas bridging galaxy cluster pair
2012-11-20
ESA's Planck space telescope has made the first conclusive detection of a bridge of hot gas connecting a pair of galaxy clusters across 10 million light-years of intergalactic space.
Planck's primary task is to capture the most ancient light of the cosmos, the Cosmic Microwave Background, or CMB. As this faint light traverses the Universe, it encounters different types of structure including galaxies and galaxy clusters – assemblies of hundreds to thousands of galaxies bound together by gravity.
If the CMB light interacts with the hot gas permeating these huge cosmic ...
Music to the ears for a good night's sleep?
2012-11-20
WINSTON-SALEM, N.C. – Nov. 20, 2012 – If you are among the 50 percent of Americans who suffer from insomnia, then you have probably tried everything – from warm milk to melatonin pills or prescription medications to induce sleep – with varying degrees of success and side effects. But what if sleep could be achieved not by a substance, but through 'balancing' brain activity?
Researchers at Wake Forest Baptist Medical Center have conducted a pilot clinical study to determine whether a non-invasive approach, that uses musical tones to balance brain activity, can 'reset' ...